ArticleThe AAPS journal2026
Identification of HLA Variants Associated with Symptomatic and Asymptomatic COVID-19 Using a Machine Learning Approach.
Article in The AAPS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 disease outcomes can vary considerably among infected patients. Most studies have focused on patients with severe COVID-19. However, investigations of asymptomatic infection can provide insights into patient-specific immunological features that protect patients from COVID-19 symptoms. Recent studies have shown an association between common human leukocyte antigen (HLA) alleles and asymptomatic COVID-19 infections. Here we utilize machine learning in conjunction with explainable AI (XAI) to identify alleles in five HLA loci that can be either protective or put the patient at risk for symptomatic COVID-19. Data from the public online HLA-COVID database (1946 samples) was used for training and validating multiple ML classification models to identify the top performing model. The model was then further processed with XAI via SHAP (SHapley Additive exPlanations) to identify the protective and high-risk HLA alleles. This study provides a proof-of-concept study for utilizing machine learning to provide valuable insights for COVID-19 patients. These findings can be translated into clinical algorithms to help physicians personalize COVID-19 treatments and achieve better clinical outcomes.
Indexed as
Identifiers
41588244What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.